TCR-signaled CTLs can then induce cancer cell death via multiple pathways, including by degranulation, which releases perforin (PRF)/granzyme B (GZMB), or by upregulation of FasL or TRAIL that signal cancer cell apoptotic pathways (Figure 1A). The gene discussed is GZMB; the disease is cancer.